Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01041547 · ClinicalTrials.gov registry record

Vascular Function, Insulin Sensitivity, and Vitamin D

A clinical trial, sponsored by University of Alabama at Birmingham.

Completed
Registry status
63
Enrollment target

NCT01041547 is a clinical trial that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 63 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01041547 has completed, sponsored by University of Alabama at Birmingham.

COMPLETED
Registry status
63 participants
Enrollment target

Study Summary

The overall objectives of this study are to examine the relationships between circulating vitamin D, insulin sensitivity, and multiple indices of vascular function and to examine whether vitamin D deficiency in African Americans (AA) and White Hispanics (WH) is responsible for ethnic differences in insulin sensitivity and hypertension in AA, WH and European Americans (EA), as well as mechanisms underlying the association between insulin resistance and blood pressure. We hypothesize that 1) serum 25(OH)D is associated with insulin sensitivity and vascular functioning, independent of adiposity, 2) lower insulin sensitivity and vascular functioning in AA and WH relative to EA is due to lower circulating 25(OH)D in AA, and 3) the relationship between insulin resistance and vascular dysfunction is mediated by 25(OH)D. Acronyms: African American (AA), European American (EA), White Hispanics (WH), Serum 25-hydroxy vitamin D (25()H)D, Body mass index (BMI), Alabama (AL).

Trial Details

FieldValue
Enrollment Target 63 participants
Start Date 2009-12
Est. Completion 2013-12

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT01041547

The ClinicalTrials.gov registry entry for NCT01041547 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 63 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 0 interventions.

NCT01041547 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01041547 about?

NCT01041547 is a clinical study titled "Vascular Function, Insulin Sensitivity, and Vitamin D". The overall objectives of this study are to examine the relationships between circulating vitamin D, insulin sensitivity, and multiple indices of vascular function and to examine whether vitamin D deficiency in African Americans (AA) and White Hispanics (WH) is responsible for ethnic differences in ...

What is the current status of trial NCT01041547?

This trial is currently completed. The enrollment target is 63 participants. The study started on 2009-12. Estimated completion is 2013-12.

Who is sponsoring clinical trial NCT01041547?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.